What Happened to Foster Children in HIV Drug Trials?

A Child Safety Perspective

In the 1990s and early 2000s, a difficult and troubling situation unfolded in the United States.

Hundreds of children in foster care — many of them Black and Latino — were enrolled in clinical trials for HIV/AIDS medications.

These trials were funded by the National Institutes of Health (NIH) and conducted at major medical research institutions across several states. New York City became the center of public controversy after journalists and advocates began asking questions about how foster children had been enrolled.

The issue raised an important question that still matters today:

How do we protect children who are already vulnerable when major systems make decisions about their lives?

Why These Trials Happened

To be fair, we must remember the moment in history.

During the late 1980s and 1990s, the AIDS epidemic was devastating families across the United States.

Many babies were born with HIV after their mothers contracted the virus. At the time:

• Treatments for children were extremely limited

• Most HIV medications had only been tested on adults

• Thousands of children were becoming sick

Many of these children entered foster care because their parents were too ill to care for them or had died from AIDS-related illnesses.

Researchers began studying whether new antiretroviral medications could help these children survive.

Why Concerns Were Raised

In the early 2000s, investigations began into how these trials were conducted.

Advocates raised several serious concerns:

• Some children were enrolled without independent legal advocates, which federal rules require for children who are wards of the state.

• Oversight and documentation were sometimes incomplete or poorly recorded.

• Some children experienced serious side effects, including rashes, vomiting, and drops in white blood cell counts.

• At least ten children died during the period of the trials, though investigators later reported that the deaths were linked to the severity of AIDS rather than the medications themselves.

Federal investigators later confirmed that some ethical and procedural rules had been broken, particularly around oversight and advocacy for the children.

Why the Story Still Matters

Even when medicine is trying to save lives, the rights and safety of children must remain the highest priority.

Foster children are among the most vulnerable children in any system. They often have:

• no consistent advocate

• no stable adult speaking for them

• no ability to give informed consent

That is why federal law requires special protections when children who are wards of the state are involved in research.

When those protections fail, trust is damaged.

The Deeper Historical Context

For many communities — especially Black communities — these events also touched a deeper historical wound.

America has a long history of medical experimentation involving vulnerable populations, including:

• enslaved Black people used in medical experimentation

• the Tuskegee Syphilis Study

• forced sterilization under eugenics policies

• experimentation in institutions housing disabled people

Because of this history, even ethical medical research must be conducted with extreme transparency and protection.

Trust must be earned, not assumed.

What Safe Adults Can Learn

This history reminds us of an important truth.

Children need adults who are willing to ask questions, demand safeguards, and ensure that systems treat them with dignity.

Safe adults must pay attention to:

• who is making decisions for children
• whether children have independent advocates
• whether protections required by law are actually being followed

Children should never be invisible inside institutions. Institutions must remain transparent through ALL phases.

They should always have someone who is watching carefully on their behalf.

Moving Forward

Medical research has helped turn HIV from a fatal disease into a manageable condition for many people today.

But progress should never come at the cost of ignoring the voices and protections of vulnerable children.

The lesson for today is simple:

Children deserve protection first.
Research, policy, and institutions must follow that principle — every time.